Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Cipla, Macleods HIV child treatments approved in South Africa

Ruchika Sharma27 Jun 2022 12:30 PM IST

New Delhi: South Africa, which has the world's biggest number of people infected with HIV, has approved Cipla Ltd.'s quadrimune, a treatment for...

Govt advisory panel to review trial data on Serum Institute qHPV vaccine against cervical cancer

Ruchika Sharma27 Jun 2022 11:29 AM IST

New Delhi: The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus (qHPV)...

Bristol Myers Squibb bags USFDA nod for CAR T Cell Therapy Breyanzi

Ruchika Sharma26 Jun 2022 4:00 PM IST

Breyanzi, a differentiated CAR T cell therapy, is made from a patient's own T cells, which are collected and genetically reengineered to become CAR T...

Sinovac Biotech COVID vaccine CoronaVac conditionally registered in South Africa

Ruchika Sharma26 Jun 2022 2:30 PM IST

China: Sinovac Biotech Ltd. has announced that the South African Health Products Regulatory Authority (SAHPRA) has granted conditional registration to...

Novavax COVID vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents

Ruchika Sharma26 Jun 2022 12:30 PM IST

NVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.

Valneva COVID vaccine gets marketing authorization in Europe

Ruchika Sharma26 Jun 2022 10:00 AM IST

VLA2001 is the whole virus, inactivated, adjuvanted COVID-19 vaccine.

Pfizer sets sights on elimination of blinding disease trachoma by 2030

Ruchika Sharma26 Jun 2022 9:00 AM IST

The ITI had initially hoped to eliminate the disease by 2020, but is now setting its sights on 2030.

Bristol Myers Squibb must face USD 6.4 billion lawsuit over delayed cancer drug

Ruchika Sharma25 Jun 2022 3:30 PM IST

The case arose from the company's agreement to pay Celgene shareholders holding "contingent value rights" an extra $9 per share in cash if it won U.S....

Delhi HC Orders Arbitration in Medikabazaar Board Dispute, Tiwari Challenges Termination

Delhi HC relief to Intas- Stops two pharma companies from violating trademark of LOOZ

Ruchika Sharma25 Jun 2022 2:30 PM IST

New Delhi: The Delhi High Court has permanently restrained two pharmaceutical manufacturers from using the trademark 'LOOZOUT' in their products,...

BioNTech in conflict with regulator over new COVID vaccine nod: WAS newspaper

Ruchika Sharma25 Jun 2022 1:30 PM IST

The reason for this was that the approval "should go through the same regulatory process as ordinary flu vaccines", which would allow the new COVID-19...

CDSCO panel recommends emergency use nod for SII Covovax for kids aged 7 to 11 years

Ruchika Sharma25 Jun 2022 12:45 PM IST

The recommendation has been sent to Drugs Controller General of India (DCGI) for final approval.

USFDA concludes inspection at Dr Reddys Labs Srikakulam API facility

Dr Reddys acquires injectable product portfolio from Eton Pharma for Rs 391 crore

Ruchika Sharma25 Jun 2022 11:49 AM IST

"The acquisition supports Dr. Reddy's efforts to accelerate and expand affordable medications for patients," the company stated.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok